The next trial based announcement to come out should be the outcome of the Secondary Measures at 100 days for the aGVHD P3 trial which is estimated to be recorded this month, April, and that is from a "Last Update Posted : April 5, 2018"
https://clinicaltrials.gov/ct2/show/NCT02336230
My best guess based on the publication date of the Primary Measures at 28 days on 23 February (then counting another 72 days), would be some news on the Secondary Measures at 100 days around the first or second week of May.
A couple of weeks is a long time on the ASX so maybe there is something else brewing.
Add to My Watchlist
What is My Watchlist?
